Abbott to Acquire St. Jude Medical
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
Go back to Abbott to Acquire St. Jude Medical
April 28, 2016 11:38 AM EDT
Standard & Poor's Ratings Services stated that its ratings on Abbott Laboratories (NYSE: ABT), including the 'A+' corporate credit and 'A-1+' commercial paper ratings, remain on CreditWatch with negative implications. The CreditWatch update follows Abbott's offer to acquire St. Jude Medical for roughly $31 billion (including $6 billion of assumed St. Jude debt). This transaction is in addition to the planned roughly $9 billion debt-funded acquisition of Alere.
"We believe that when completed, the acquisition of St. Jude Medical would significantly strengthen Abbott's position in the medical device industry as well as broaden its already very... More
April 28, 2016 7:13 AM EDT
Abbott (NYSE: ABT) filed the agreement terms of its proposed takeover of St. Jude Medical (NYSE: STJ). The following was noted on Thursday:
Section 10.03 Termination Fees.
(a) In the event that... More
